Absci Corporation (ABSI) is working on developing the use of its biological drug ABS-101 for the treatment of patients with inflammatory bowel disease [IBD]. This drug is already de-risked in the fact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback